Mostrando ítems 1-5 de 5
Identification of resistance mechanism to targeting of the ADAM 17/ EGFR axis in triple negative breast cancer in vivo
(Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica, 2015)
Mostrando ítems 1-5 de 5